Stockreport

Cellectar nabs new patent in Europe for CLR 131 [Seeking Alpha]

Cellectar Biosciences, Inc.  (CLRB) 
Last cellectar biosciences, inc. earnings: 11/12 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.cellectar.com
PDF Cellectar Biosciences (NASDAQ:CLRBannouncesThe patent provides composition of matter and use protection for the treatment and/or diagnosis of cancer and cancer stem cell [Read more]